for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Westlaw News

GSK urges U.S. court to revive $235 million patent verdict against Teva

A federal appeals court appeared divided during oral argument on Wednesday over whether to resurrect a jury verdict that required Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline PLC more than $235 million for infringing a patent covering its blood pressure drug Coreg.

A three-judge panel of the U.S. Court of Appeals for the Federal Circuit heard oral arguments in GSK’s appeal of a post-trial ruling that vacated the 2017 verdict.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2lDX6W2

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up